Category: Publications

A how-to-guide to building a robust SARS-CoV-2 testing program at a university-based health system

When South Florida became a hotspot for COVID-19 disease in March 2020, we faced an urgent need to develop test capability to detect SARS-CoV-2 infection.

8. June 2020

Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium: a prospective cross-sectional study of residual samples

In the first weeks of the COVID-19 epidemic in Belgium, a repetitive national serum collection was set up to monitor age-related exposure through emerging SARS-CoV-2 antibodies.

8. June 2020

Dynamics of the SARS-CoV-2 epidemic in the earliest-affected areas in Italy: 1 Mass screening for SARS-CoV-2 serological positivity (SARS-2-SCREEN).

Several municipalities in the Lombardy Region have been affected by the SARS-CoV-2 infection since the earliest stages of the epidemic.

8. June 2020

Covid-19 Seroprevalence rate in healthy blood donors from a community under strict lockdown measures

Covid-19 seroprevalence rates and serological tests are important tools in understanding the epidemiology of the disease and help in the fight against it.

7. June 2020

Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing

The serosurvey is an alternative way to know the magnitude of the population infected by coronavirus disease 2019 (COVID-19) since the expansion of capacity of the polymerase chain reaction (PCR) to detect the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was delayed.

4. June 2020

High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay

Serological testing is needed to investigate the extent of transmission of SARS-CoV-2 from front-line essential workers to their household members.

2. June 2020

Antibody profiling of COVID-19 patients in an urban low-incidence region in Northern Germany

This explorative monocentric study shows IgA and IgG antibody profiles from 110 patients with self-reported mild to moderate, or no COVID-19 related symptoms after laboratory-confirmed infection with SARS-CoV-2.

2. June 2020

The prevalence of antibodies to SARS-CoV-2 in asymptomatic healthcare workers with intensive exposure to COVID-19

The prevalence of asymptomatic SARS-CoV-2 infection in healthcare workers with intensive exposure to COVID-19 is unclear.

2. June 2020

Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City

SARS-CoV-2 antibody testing is important for understanding immunity prevalence, and may have implications for healthcare workers (HCW) during the SARS-CoV-2 pandemic.

2. June 2020

Remarkable variability in SARS-CoV-2 antibodies across Brazilian regions: nationwide serological household survey in 27 states

Population based data on COVID-19 are essential for guiding policy.

30. May 2020

« Previous Page1 Page2 Page3 Page4 Page5 Next »

Plattform for seroprevalence studies on SARS-COV-2

Privacy Policy
Impress